HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bispecific monoclonal antibodies to human interleukin 2 and horseradish peroxidase.

Abstract
Hybrid hybridomas (tetradomas), producing bispecific monoclonal antibodies (bmabs) binding to both interleukin 2 and horseradish peroxidase were obtained by fusing IL 2-specific and HRP-specific hybridomas. Parental hybridomas were labelled prior to the fusion with fluorescein isothiocyanate and tetramethylrhodamine isothiocyanate. Bifluorescent (tetradoma) cells were sorted out using fluorescence activated cell sorter. Two clones, designated D8C1/G and H7C11/H were shown to secrete bmabs over at least 6 months growth in culture. Bmabs have been purified from mouse ascites by ammonium sulfate precipitation and affinity chromatography on immobilized peptide, modelling corresponding IL 2 epitope. The purity of antibodies obtained was characterized by capillary electrophoresis. The possibility of using these antibody preparations in rIL 2 analysis was evaluated in two types of EIA: direct and competitive solid-phase EIA. Both assays had similar sensitivity of about 1.5-4 ng IL 2 per ml.
AuthorsP A Stratieva-Taneeva, S V Khaidukov, V A Kovalenko, I V Nazimov, L V Samokhvalova, V A Nesmeyanov
JournalHybridoma (Hybridoma) Vol. 12 Issue 3 Pg. 271-84 (Jun 1993) ISSN: 0272-457X [Print] United States
PMID8359822 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Fluorescent Dyes
  • Immunoglobulin G
  • Interleukin-2
  • Recombinant Proteins
  • Horseradish Peroxidase
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antibody Specificity
  • Binding Sites, Antibody
  • Cell Fusion
  • Cell Separation
  • Flow Cytometry
  • Fluorescent Dyes
  • Horseradish Peroxidase (immunology)
  • Humans
  • Hybridomas (immunology)
  • Immunoenzyme Techniques
  • Immunoglobulin G (immunology)
  • Interleukin-2 (immunology)
  • Mice
  • Recombinant Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: